Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

GalNAc-T13 Activators

GalNAc-T13 activators belong to a specialized class of chemical compounds aimed at modulating the activity of the enzyme N-acetylgalactosaminyltransferase 13 (GalNAc-T13). This enzyme is part of a larger family of GalNAc-transferases involved in the process of glycosylation, where they catalyze the transfer of N-acetylgalactosamine (GalNAc) to serine and threonine residues on proteins, a form of post-translational modification that affects protein folding, stability, and function. GalNAc-T13 has a specific role within this family, with a unique substrate specificity that determines its selectivity for certain proteins. Activators of GalNAc-T13 are designed to enhance the enzyme's natural activity, which could result in increased glycosylation of its target substrates. To develop these activators, a comprehensive understanding of the enzyme's structure, catalytic mechanism, and substrate interaction is required. This includes insights into the active site where the transfer of GalNAc from the donor molecule, typically uridine diphosphate N-acetylgalactosamine (UDP-GalNAc), to the acceptor amino acid on the target protein takes place.

Creating GalNAc-T13 activators entails a process of identifying and synthesizing molecules that can interact with the enzyme to boost its glycosyltransferase activity. This might involve molecules that bind to allosteric sites, altering the enzyme's conformation to a more active state, or compounds that increase the enzyme's affinity for its substrates. These activators are designed using a range of techniques, such as computer-aided drug design and high-throughput screening, to find structures that specifically enhance the function of GalNAc-T13. The activators must be able to interact precisely with the enzyme to avoid nonspecific activation of other GalNAc-transferases or off-target effects within the cell. Once potential activators are identified, they undergo a series of optimizations to improve their efficacy and specificity. This iterative process involves tweaking the chemical structure of the compounds, assessing their impact on the enzyme's activity, and ensuring that they are selective for GalNAc-T13. The resulting molecules are typically characterized by their ability to form stable and specific interactions with the enzyme, possibly involving hydrogen bonding, hydrophobic interactions, and Van der Waals forces, which are crucial for the selective and potent activation of GalNAc-T13.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic acid could potentially upregulate GalNAc-T13 when it induces changes in gene expression during cell differentiation and proliferation.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

During its anti-inflammatory response, dexamethasone might upregulate several genes, potentially including GalNAc-T13.

β-Estradiol

50-28-2sc-204431
sc-204431A
500 mg
5 g
$63.00
$182.00
8
(1)

In hormone-responsive tissues, β-Estradiol could potentially upregulate GalNAc-T13 along with other genes.

Cholecalciferol

67-97-0sc-205630
sc-205630A
sc-205630B
1 g
5 g
10 g
$71.00
$163.00
$296.00
2
(1)

Cholecalciferol could potentially upregulate GalNAc-T13 when it influences gene expression via the vitamin D receptor.

(−)-Epinephrine

51-43-4sc-205674
sc-205674A
sc-205674B
sc-205674C
sc-205674D
1 g
5 g
10 g
100 g
1 kg
$41.00
$104.00
$201.00
$1774.00
$16500.00
(1)

Epinephrine could potentially upregulate GalNAc-T13 when it influences gene expression through signal transduction pathways.

Insulin

11061-68-0sc-29062
sc-29062A
sc-29062B
100 mg
1 g
10 g
$156.00
$1248.00
$12508.00
82
(1)

Through its metabolic roles, insulin might upregulate certain genes, potentially including GalNAc-T13.

Folic Acid

59-30-3sc-204758
10 g
$73.00
2
(1)

Folic acid could potentially upregulate GalNAc-T13 as part of its influence on DNA synthesis and repair.

Caffeine

58-08-2sc-202514
sc-202514A
sc-202514B
sc-202514C
sc-202514D
50 g
100 g
250 g
1 kg
5 kg
$33.00
$67.00
$97.00
$192.00
$775.00
13
(1)

Caffeine might upregulate GalNAc-T13 along with other genes, potentially via signal transduction pathways.

L-Ascorbic acid, free acid

50-81-7sc-202686
100 g
$46.00
5
(1)

Ascorbic Acid (Vitamin C) could potentially upregulate GalNAc-T13 when it influences gene expression as part of cellular metabolism.

Atorvastatin

134523-00-5sc-337542A
sc-337542
50 mg
100 mg
$257.00
$505.00
9
(1)

Atorvastatin might upregulate GalNAc-T13 as part of its potential influence on genes involved in lipid metabolism.